Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Fewer Low Birth Weight Deliveries Seen Following Ban On PFOA in Teflon: Study December 1, 2017 Martha Garcia Add Your CommentsFollowing a decision the ban the chemical used to make Teflon, the number of infants born nationwide with low-birth weight has dropped, according to the findings of new research.ย In a study published in the International Journal of Hygiene and Environmental Health, researchers from New York University’s School of Medicine indicate that lower levels of perfluorooctanoic acid (PFOA) in women’s blood was associated with a reduction in the number of low birth weight deliveries after the chemical was banned.PFOA is used to make products that resist heat, oil stains, grease, and water. The chemicals are commonly used to manufacture Teflon, nonstick cookware, food packaging, electronics, and carpets.Do You Know about…Spinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONDo You Know AboutโฆSpinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONIn 2003, the industry initiated a self-regulated phase out of PFOAs, coupled with EPA regulatory activities by 2014. ย The ban followed studies linking PFOA chemicals to adverse health effects, including suppressed immune systems, cancer, increasing hypersensitivity in humans, and lower birth weights among newborns.Researchers focused on blood levels of PFOAs after a phase-out of the chemical began in 2003, culminating in the ban by 2014. Researchers used data from the National Health and Nutrition Examination Survey (NHANES) for 2003 to 2014. They measured blood levels of PFOAs among women 18 to 49 years old. Birth weights for their children were obtained from Vital Statistics Natality Birth Data.Although the phase out was initiated in 2003, PFOA rates did not begin to decline until 2009, according to the findings. The data indicated serum PFOA levels remained constant for 2003โ2004, with an average of 3.3 nanograms per milliliter (ng/mL). Average rates for 2007โ2008 measured 3.5 ng/mL. By 2009โ2010, rates began to decline, with levels at 2.8 ng/mL and 1.6 ng/mL from 2013โ2014.Low birth weight attributed to PFOA exposure for 2003โ2014 was estimated at $13.7 billion. However, that cost declined steadily following the ban, with a cost of roughly $2.97 billion in the 2003โ2004 timeframe, $2.4 billion from 2009โ2010, and $347 million by 2013โ2014.Researchers estimated nearly 13,000 cases of infants with low-birth weight could have been prevented in 2003โ2004 if PFOAs were phased out sooner.ย Another 10,000 could have been prevented for the 2009โ2010 time frame, and about 1,500 for the 2012โ2014 time period.Researchers say the combination of both the industry phase out and the eventual ban helped to greatly reduce PFOA exposure, and thus, reduce the incidence of low-birth weight babies.However, the effects of PFOA still linger and continue to have other health side effects. A study published in 2016 indicated more than 6 million Americans are at risk of side effects from water supplies contaminated with PFOA in the U.S. Chemicals, including PFOAs and others, were detected in more than 200 water supplies across the country.A panel of scientists convened in 2016 warned that while PFOA use in consumer products and emissions have been reduced, PFOAs are still widely detectable in the U.S. population. Written by: Martha GarciaHealth & Medical Research WriterMartha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. Tags: Chemicals, Low Birth Weight, PFOA, Water ContaminationMore Lawsuit Stories Bard PowerPort Infection Lawsuit Claims Catheter Fractures Harbored Bacteria November 3, 2026 Chlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns November 3, 2026 Medtronic Insulin Pump Lawsuit Filed Over Recalled MiniMed 600 Series Device November 3, 2026 0 Comments LinkedInThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Bard PowerPort Infection Lawsuit Claims Catheter Fractures Harbored Bacteria (Posted: today)An Illinois man’s lawsuit accuses C.R. Bard of using a defective material in its PowerPort port catheter’s construction, causing him to suffer an infection and device failure.MORE ABOUT: BARD POWERPORT LAWSUITFourth Bard PowerPort Bellwether Case Set for Trial Dec. 1, as Third Gets Underway (10/14/2026)Judge Clears Bard PowerPort Lawsuit for Trial, Rejecting Motion for Summary Judgment (10/02/2026)Bard PowerPort Infection Lawsuit Set for Third Bellwether Trial to Begin Oct. 13 (09/14/2026) Abbott Sales Reps Kept Trying to Reprogram Failed SCS Implant: Lawsuit (Posted: yesterday)An Abbott SCS Implant lawsuit claims the manufacturers’ sales representatives potentially delayed removal of a failed device due to attempts to try to reprogram it.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITAbbott Proclaim Elite Lawsuit Alleges Spinal Cord Stimulator Malfunction Worsened Chronic Pain (10/29/2026)Boston Scientific Spectra WaveWriter Lawsuit Alleges Lead Fracture, Migration and Painful Electric Shocks (10/21/2026)Abbott Spinal Cord Stimulator Lead Problems Caused Burning, Shocks, Lawsuit Alleges (10/16/2026) Ozempic Blindness Lawsuit Alleges Novo Nordisk Concealed NAION Risks (Posted: 4 days ago)A woman’s lawsuit accuses Novo Nordisk of ignoring and downplaying risks of vision loss linked to GLP-1 drugs like Ozempic.MORE ABOUT: OZEMPIC LAWSUITGLP-1 Vision Loss Lawsuit Alleges Ozempic Caused Man to Become Legally Blind (10/13/2026)Ozempic Injection Lawsuit Claims Diabetes Medication Caused Vision Loss (09/22/2026)Lawsuit Blames Mounjaro, Ozempic Side Effects for Vision Loss (09/15/2026)
Chlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns November 3, 2026
Bard PowerPort Infection Lawsuit Claims Catheter Fractures Harbored Bacteria (Posted: today)An Illinois man’s lawsuit accuses C.R. Bard of using a defective material in its PowerPort port catheter’s construction, causing him to suffer an infection and device failure.MORE ABOUT: BARD POWERPORT LAWSUITFourth Bard PowerPort Bellwether Case Set for Trial Dec. 1, as Third Gets Underway (10/14/2026)Judge Clears Bard PowerPort Lawsuit for Trial, Rejecting Motion for Summary Judgment (10/02/2026)Bard PowerPort Infection Lawsuit Set for Third Bellwether Trial to Begin Oct. 13 (09/14/2026)
Abbott Sales Reps Kept Trying to Reprogram Failed SCS Implant: Lawsuit (Posted: yesterday)An Abbott SCS Implant lawsuit claims the manufacturers’ sales representatives potentially delayed removal of a failed device due to attempts to try to reprogram it.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITAbbott Proclaim Elite Lawsuit Alleges Spinal Cord Stimulator Malfunction Worsened Chronic Pain (10/29/2026)Boston Scientific Spectra WaveWriter Lawsuit Alleges Lead Fracture, Migration and Painful Electric Shocks (10/21/2026)Abbott Spinal Cord Stimulator Lead Problems Caused Burning, Shocks, Lawsuit Alleges (10/16/2026)
Ozempic Blindness Lawsuit Alleges Novo Nordisk Concealed NAION Risks (Posted: 4 days ago)A woman’s lawsuit accuses Novo Nordisk of ignoring and downplaying risks of vision loss linked to GLP-1 drugs like Ozempic.MORE ABOUT: OZEMPIC LAWSUITGLP-1 Vision Loss Lawsuit Alleges Ozempic Caused Man to Become Legally Blind (10/13/2026)Ozempic Injection Lawsuit Claims Diabetes Medication Caused Vision Loss (09/22/2026)Lawsuit Blames Mounjaro, Ozempic Side Effects for Vision Loss (09/15/2026)